Signal Over Noise: Playing Offense And Defense Through Health Care

This report highlights the health care sector as a strategic asset for both defense and growth, driven by the emergence of GLP-1 drugs and AI-enhanced drug discovery. UBS emphasizes that these factors create a compelling long-term opportunity despite the sector's previous underperformance compared to other growth themes.

Key Takeaways

• 1.The health care sector serves as a defensive portfolio ballast while offering underappreciated growth through pharmaceutical innovation.
• 2.GLP-1 drugs are creating a massive new pharmaceutical market by shifting treatment paradigms from symptoms to root causes.
• 3.Artificial intelligence and genomics are transforming drug development by reducing failure rates and capital costs.

Table of Contents

• Signal over Noise: Playing offense and defense through health care
• Global asset class preferences definitions
• Appendix
• Risk information